cenicriviroc/tropifexor (LJC242) - Novartis, AbbVie
Rezdiffra (resmetirom) - Madrigal Pharma
efruxifermin (AKR-001) - Akero Therap
cenicriviroc (TBR-652) - Takeda, AbbVie
simtuzumab (GS 6624) - Gilead
aldafermin (NGM282) - NGM Biopharma
pegozafermin (BIO89-100) - 89Bio
pioglitazone - Generic mfg.
selonsertib (GS-4997) - Gilead
https://www.apasl2024kyoto.org/docs/info/Abstract_Book_(Tentative)_APASL_2024_Kyoto_20240302.pdf
 
Douglas Chee1; Jia Hong Koh1; Benjamin Nah1; Margaret Teng1, 3; Cheng Han Ng1; Daniel Huang1, 2, 3; Mark Muthiah0
 
Jan 6, 2024
 
Prev Next